Latest News & Updates | Lymphoma Canada Announcements

News

Canadian Institute for Health Research doubles gifts to LC

Do you believe things happen for a reason? I would like to share with you…

lauradMarch 15, 2013

News

Celebrating Health Canada’s Approval of ADCETRIS

Lymphoma Canada celebrates Health Canada’s Approval of ADCETRIS (Brentuximab Vedotin)

lauradFebruary 13, 2013

Research

Bendamustine for treatment of iNHL and MCL

Lymphoma is the fifth most common malignancy in Canada that is expected to cause 2800…

lauradDecember 1, 2012

Research

Rituximab and Elderly Mantle Cell Patients

A study published in the New England Journal of Medicine showed that maintenance theraphy with…

lauradDecember 1, 2012

Research

Bendamustine added to BC Drug Benefit List

The BC Cancer Agency, in the November 2012 Systemic Therapy Update, has added bendamustine (Treanda®)…

lauradNovember 13, 2012

News

World Lymphoma Awareness Day 2012

2012 World Lymphoma Awareness Day Saturday, September 15, 2012 We are extremely proud to be…

lauradSeptember 13, 2012

Research

New Treatment Option for Relapsed Indolent B-cell Non-Hodgkin Lymphoma

MONTREAL, QUEBEC, Sep 13, 2012 (MARKETWIRE via COMTEX) -- Editors note: There is a video…

lauradSeptember 13, 2012

News

New Staff Announcement

Vaughan Reid as National Development Manager and Charlene Ragin as Marketing and Communications Coordinator.

lauradSeptember 7, 2012

Research

New Program Launched For Safe Medication Use.

Seven of Canada's leading health care organizations have joined together to launch new electronic tools…

lauradJune 25, 2012

Research

Report Card on Wait Times In Canada Released

The absence of a concerted national effort to reduce wait times is undermining progress on…

lauradJune 25, 2012

Mon	Tue	Wed	Thu	Fri	Sat	Sun
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

News & Media

Canadian Institute for Health Research doubles gifts to LC

Celebrating Health Canada’s Approval of ADCETRIS

Bendamustine for treatment of iNHL and MCL

Rituximab and Elderly Mantle Cell Patients

Bendamustine added to BC Drug Benefit List

World Lymphoma Awareness Day 2012

New Treatment Option for Relapsed Indolent B-cell Non-Hodgkin Lymphoma

New Staff Announcement

New Program Launched For Safe Medication Use.

Report Card on Wait Times In Canada Released

Are you a patient?

Are you a healthcare professional?

Upcoming Events

Contact Us

Donate

Careers

Join Our Mailing List